Skip to Content


Jan 10 2022

The annual H.C. Wainright Bioconnect conference will take place virtually this year from January 10 to 13. This event offers investors the opportunity to listen to presentations from participating companies and take part in fireside discussions, one-to-one investor meetings, meetings with H.C. Wainwright investment banking and research teams, and an evening of virtual entertainment. 


Laurent Levy, Chief Executive Officer at Nanobiotix will present on January 10 at 7:00 AM (EST) / 1:00 PM (CET). During this presentation, he will share updates about our work and our clinical development strategy for NBTXR3. The presentation of the event will be available on this link.